HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prevagen ‘Improves Memory’ Claims Will Be Qualified Under Class Action Settlement

Executive Summary

Quincy Bioscience doesn’t admit to “any liability or wrongdoing of any kind associated with the claims alleged” in settlement to complaint in federal court in Florida, but agrees to pay plaintiffs refunds of 30% of the MSRP for its supplements, up to $70 per individual claimant.

You may also be interested in...



Class Action Against Prevagen 'Improve Memory' Claim Unravels On Consumer's Memory Lapse

Prevagen containers since 2013 have been labeled with an "improve memory," but the package a plaintiff purchased in 2014 apparently didn't bear the claim, according to a court ruling. A receipt for the purchase indicated the product was identified with “Brain Cell Protection” on the label.

Fewer Arrows Left In Quincy's Quiver To Defend Against FTC's Prevagen Supplement Complaint

"There is no need to litigate the same issue again," says District Judge Louis Stanton in granting most of the joint motions by FTC and New York attorney general to strike Quincy Bioscience's proposed defenses. The judge denied other motions, including whether NY state laws are applicable, saying a trial is needed to weigh the evidence.

Prevagen Among Magazine's Top 'Brain' Supplements; FTC Complaint Ongoing

Prevagen among four products named “Best of Supplements” for "brain health" by Better Nutrition Magazine. FTC proceeds with complaint against the firm, which filed responses to the agency's complaint after the litigation was returned to US district court.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel